论文部分内容阅读
1000亿:太极要做中国药企的“亚马逊”在金融危机冲击、经济发展压力巨大的2012年,太极集团为何能逆势上扬?太极集团董事局主席白礼西为我们提供了答案:“二次创业激发原动力,太极人正以奋发图强的创业精神,朝着‘10年铸就千亿太极’宏伟目标迈进!到2020年,太极集团的医药商业将突破600亿元,医药工业及配套产业将突破400亿元!”盘踞医药主战场厚积薄发近几年,国家对中医药传统产业及国有医药企业的扶植力度不断增强。即将公布医药行业相关的三个“十二五”规划也指向——扶植制药巨头、提高医药流通行业集中度、力促民族药发展。“十年来,太极集团在
100 billion: Taiji to do the ”Amazon“ of Chinese pharmaceutical companies In 2012, when the financial crisis hit, and the pressure of economic development was huge, why did the Taiji Group rise against the trend? Chairman of the Taiji Group’s Board of Directors Bai Lixi provided us with the answer: ”The second entrepreneurship stimulates the motive force. Tai Chi people are struggling to create a strong entrepreneurial spirit and are moving toward the grand goal of ’100 billion Tai Chi’ in 10 years! By 2020, the Tai Chi Group’s pharmaceutical business will exceed 60 billion yuan, the pharmaceutical industry and supporting facilities. The industry will break through 40 billion yuan!“ Panyu medicine’s main battlefield has accumulated a lot in recent years, and the state’s support for the traditional Chinese medicine traditional industries and state-owned pharmaceutical companies has continued to increase. The upcoming publication of the three “Twelve Five-Year Plan” related to the pharmaceutical industry also points to – fostering pharmaceutical giants, increasing the concentration of the pharmaceutical distribution industry, and promoting the development of national medicine. ”Ten years ago, Tai Chi Group is